Department of Cardiovascular Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
Department of Cardiovascular Medicine, West Virginia University Hospital, Morgantown, WV, USA.
Vasc Med. 2024 Apr;29(2):135-142. doi: 10.1177/1358863X231205574. Epub 2023 Nov 7.
Atherosclerotic cardiovascular disease is highly prevalent in patients with end-stage kidney disease (ESKD). Kidney transplant (KT) improves patient survival and cardiovascular outcomes. The impact of preexisting coronary artery disease (CAD) and peripheral artery disease (PAD) on posttransplant outcomes remains unclear.
This is a retrospective study utilizing the United States Renal Data System. Adult diabetic dialysis patients who underwent first KT between 2006 and 2017 were included. The study population was divided into four cohorts based on presence of CAD/PAD: (1) polyvascular disease (CAD + PAD); (2) CAD without PAD; (3) PAD without CAD; (4) no CAD or PAD (reference cohort). The primary outcome was 3-year all-cause mortality. Secondary outcomes were incidence of posttransplant myocardial infarction (MI), cerebrovascular accidents (CVA), and graft failure.
The study population included 19,329 patients with 64.4% men, mean age 55.4 years, and median dialysis duration of 2.8 years. Atherosclerotic cardiovascular disease was present in 28% of patients. The median follow up was 3 years. All-cause mortality and incidence of posttransplant MI were higher with CAD and highest in patients with polyvascular disease. The cohort with polyvascular disease had twofold higher all-cause mortality (16.7%, adjusted hazard ratio (aHR) 1.5, < 0.0001) and a fourfold higher incidence of MI (12.7%, aHR 3.3, < 0.0001) compared to the reference cohort (8.0% and 3.1%, respectively). There was a higher incidence of posttransplant CVA in the cohort with PAD (3.4%, aHR 1.5, = 0.01) compared to the reference cohort (2.0%). The cohorts had no difference in graft failure rates.
Preexisting CAD and/or PAD result in worse posttransplant survival and cardiovascular outcomes in patients with diabetes mellitus and ESKD without a reduction in graft survival.
动脉粥样硬化性心血管疾病在终末期肾病(ESKD)患者中高度流行。肾移植(KT)可改善患者的生存和心血管结局。预先存在的冠状动脉疾病(CAD)和外周动脉疾病(PAD)对移植后结局的影响尚不清楚。
这是一项利用美国肾脏数据系统进行的回顾性研究。纳入 2006 年至 2017 年间接受首次 KT 的成年糖尿病透析患者。根据 CAD/PAD 的存在情况,将研究人群分为四组:(1)多血管疾病(CAD + PAD);(2)无 PAD 的 CAD;(3)无 CAD 的 PAD;(4)无 CAD 或 PAD(参考队列)。主要结局是 3 年全因死亡率。次要结局是移植后心肌梗死(MI)、脑血管意外(CVA)和移植物失败的发生率。
研究人群包括 19329 名男性占 64.4%、平均年龄 55.4 岁、中位透析时间 2.8 年的患者。28%的患者存在动脉粥样硬化性心血管疾病。中位随访时间为 3 年。CAD 患者的全因死亡率和移植后 MI 发生率较高,多血管疾病患者的死亡率和 MI 发生率最高。多血管疾病组的全因死亡率是参照组的两倍(16.7%,调整后的危险比(aHR)1.5,<0.0001),MI 的发生率是参照组的四倍(12.7%,aHR 3.3,<0.0001)。与参照组(分别为 3.4%和 2.0%)相比,PAD 组的移植后 CVA 发生率更高(3.4%,aHR 1.5,=0.01)。各组的移植物失败率无差异。
在没有降低移植物存活率的情况下,糖尿病合并 ESKD 患者预先存在的 CAD 和/或 PAD 导致移植后生存率和心血管结局恶化。